PerkinElmer Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
PerkinElmer Stock Forecast and Price Target
According to four experts, who recently provided their 2023 price targets for PerkinElmer, the average price target is $162.50, with a high estimate of $178.00 and a low estimate of $140.00. That is a potential upside of approximately 17.28% from the last closing price of $138.56 on January, 2023. If you are not interested in PKI stock, you may be interested in its competitors.
17.28% Upside
PerkinElmer Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's Price has grown from $72.67 to $228.68 – a 214.68% increase. In the following year, the 11 analysts surveyed believe that PerkinElmer's Fair Value will decrease by 36.71%, reaching $144.73. According to professionals, by 2030, PerkinElmer's Fair Value will have decreased by 11.99%, falling down to $201.26.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| AVGO Stock Forecast | Broadcom | Outperform |
9
|
$597.62 | $654.63 | 10.27% |
| SIE Stock Forecast | Siemens | Outperform |
6
|
145.02€ | 156.55€ | 6.88% |
| ISRG Stock Forecast | Intuitive Surgical Inc | Outperform |
15
|
$254.68 | $273.80 | 10.73% |
| MRK Stock Forecast | MERCK Kommanditgesellschaft au... | Outperform |
10
|
185.90€ | 209.03€ | 12.96% |
| GE Stock Forecast | General Electric | Outperform |
9
|
$81.96 | $86.47 | 6.15% |
PerkinElmer Revenue Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's Revenue has grown from $2.78B to $5.07B – a 82.40% increase. In the following year, the 10 analysts surveyed believe that PerkinElmer's Revenue will decrease by 9.78%, reaching $4.57B. Over the next eight years, the forecast is for Revenue to grow by 2.42%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| BDX Stock Forecast | Becton, Dickinson and | Outperform |
17
|
$245.84 | $268.00 | 11.86% |
| EMR Stock Forecast | Emerson Electric | Outperform |
10
|
$91.39 | $104.16 | 14.89% |
| ETN Stock Forecast | Eaton Corp PLC | Outperform |
10
|
$163.24 | $168.41 | 5.98% |
PerkinElmer Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's Dividend per Share has decreased from $0.28 to $0.28 – a 0.00% drop! The next year, 7 experts forecast that PerkinElmer's Dividend per Share will decrease by 0.00%, reaching $0.28. In 2030, professionals predict that PerkinElmer's Dividend per Share will decrease by 0.51%, reaching $0.28.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| DSY Stock Forecast | Dassault Systèmes | Hold |
18
|
35.09€ | 39.34€ | 15.42% |
| EW Stock Forecast | Edwards Lifesciences | Outperform |
15
|
$82.12 | $92.45 | 13.25% |
| A Stock Forecast | Agilent Technologies | Outperform |
17
|
$154.55 | $162.50 | 7.73% |
PerkinElmer Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's Free Cash Flow has grown, rising from $217.79M to $1.31B – a growth of 501.89%. For the next year, 3 analysts project PerkinElmer's Free Cash Flow to drop by 33.21%, reaching $875.57M. By 2030, professionals believe that PerkinElmer's Free Cash Flow will decrease by 15.90%, reaching $1.10B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| PH Stock Forecast | Parker-Hannifin | Outperform |
16
|
$350.00 | $338.22 | -2.57% |
| LONN Stock Forecast | Lonza Group Ltd | Outperform |
16
|
CHF457.90 | CHF756.46 | 71.98% |
| RMD Stock Forecast | ResMed | Outperform |
17
|
$224.60 | $251.67 | 12.42% |
PerkinElmer Net Income Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's Net Income has grown by 296.40%, rising from $237.93M to $943.16M. According to the 8 analysts polled, in the next year, PerkinElmer's Net Income will fall by 3.53%, reaching $909.85M. Over the next eight years, experts predict that PerkinElmer's Net Income will grow at a rate of 24.08%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| IDXX Stock Forecast | IDEXX Laboratories Inc | Outperform |
16
|
$482.41 | $479.56 | 3.65% |
| 7751 Stock Forecast | Canon | Hold |
18
|
¥2.86k | ¥0.00 | 16.95% |
| HOLX Stock Forecast | Hologic Inc | Outperform |
8
|
$84.68 | $79.86 | -2.57% |
PerkinElmer EBITDA Forecast for 2023 - 2025 - 2030
PerkinElmer's EBITDA has grown In the last three years, rising from $518.76M to $1.87B – a growth of 260.16%. According to 8 prominent analysts, PerkinElmer's EBITDA will fall by 30.96% in the next year, reaching $1.29B. By 2030, professionals believe that PerkinElmer's EBITDA will decrease by 16.53%, reaching $1.56B – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| STE Stock Forecast | STERIS | Outperform |
13
|
$219.03 | $227.00 | 0.44% |
| DGX Stock Forecast | Quest Diagnostics | Hold |
10
|
$142.81 | $147.77 | 1.18% |
| ERF Stock Forecast | Eurofins Scientific | Hold |
18
|
66.16€ | 0.00€ | 58.71% |
PerkinElmer EBIT Forecast for 2023 - 2025 - 2030
PerkinElmer's EBIT has seen impressive growth In the last three years, rising from $338.17M to $1.51B – a growth of 346.63%. In the following year, 9 experts forecast PerkinElmer's EBIT will decrease by 19.55%, to $1.22B. For the next eight years, the forecast is for EBIT to grow by 4.34%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| TECH Stock Forecast | Bio-Techne | Buy |
16
|
$79.16 | $485.91 | 31.06% |
| BIO Stock Forecast | Bio-Rad Laboratories | Buy |
16
|
$470.88 | $588.75 | 23.70% |
| CSL Stock Forecast | Carlisle Companies | Outperform |
18
|
$250.48 | $348.33 | 39.73% |
PerkinElmer EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, PerkinElmer's EPS has grown from $3.61 to $11.36 – a 214.68% increase. In the following year, the 11 analysts surveyed believe that PerkinElmer's EPS will decrease by 36.71%, reaching $7.19. According to professionals, by 2030, PerkinElmer's EPS will have decreased by 11.99%, falling down to $10.00.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| QGEN Stock Forecast | QIAGEN N.V. | Outperform |
15
|
$49.54 | $0.00 | 11.02% |
| HSIC Stock Forecast | Henry Schein Inc | Hold |
7
|
$86.76 | $82.67 | -4.33% |
| 7701 Stock Forecast | Shimadzu | Outperform |
18
|
¥3.65k | ¥0.00 | 52.05% |